Sales & Marketing News | pharmaphorum

News

Ipsen plans sale of consumer health business for €350m

Ipsen has started exclusive negotiations that could see its global consumer health business sold to fellow French pharma company Mayoly Spindler later this year.

News

GSK gets £1.4bn sales lift from COVID-19 products in 2021

GlaxoSmithKline's COVID-19 products – antibody drug Xevudy and a vaccine adjuvant – helped drive a 5% increase in 2021 revenues to £34 billion ($46 billion), ahead of what chief executive E

News

Pfizer's COVID boom goes on, as it eyes $22bn in Paxlovid sa...

Pfizer reckons it will make a whopping $22 billion in sales of its oral COVID-19 antiviral Paxlovid in 2022, with another $32 billion from its BioNTech-partnered coronavirus vaccine Comirna

News

Dr Reddy's jumps on medical cannabis train, buying Nimbus He...

India's Dr Reddy's Laboratories has joined the growing list of pharma companies that are looking to tap into the market for medical cannabis, buying German developer Nimbus Health for an un

News

COVID kits boosted Roche last year, but 2022 will be tougher

Roche has warned that revenue growth will come under pressure in the coming year as sales of its COVID-19 testing kits start to slow, exposing the impact of biosimilar competition to some o

News

Great Britain £50 - fifty pounds sterling notes spead out.

Drugmakers fined for colluding on NHS price of nausea drug

The UK Competition and Markets Authority has ruled that several drugmakers worked together to raise the NHS price of widely-used nausea drug prochlorperazine, fining them £35 million ($47.5

Ipsen plans sale of consumer health business for €350m

GSK gets £1.4bn sales lift from COVID-19 products in 2021

Pfizer's COVID boom goes on, as it eyes $22bn in Paxlovid sa...

Dr Reddy's jumps on medical cannabis train, buying Nimbus He...

COVID kits boosted Roche last year, but 2022 will be tougher

Drugmakers fined for colluding on NHS price of nausea drug

NHS to offer Wegovy to a million more people in England

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks